Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Thyroid Disorders
What are the best practices for managing moderate to severe itching due to methimazole in patients with Graves' hyperthyroidism?
Related Questions
How do you approach the use of supraphysiologic T4 doses in patients with intermediate- and high-risk differentiated thyroid cancer, considering that elevated FT4 levels have not been linked to progression-free survival in recent clinical data?
What doses of methimazole do you consider "low dose" when treating Graves' disease long-term?
How long do you recommend waiting to repeat an ultrasound in patients with cytologically benign thyroid nodules and very low to intermediate suspicion ultrasound patterns?
For patients on T4/T3 combination therapy for management of hypothyroidism is there an indication for monitoring T3 levels and if so, what is the appropriate timing (trough versus peak) given the pharmacokinetics of liothyronine?
For patients on desiccated bovine thyroid hormone therapy, how do you approach transitioning to synthetic thyroid hormone derivatives?
What are your thoughts on the possible correlation between Breast implants and thyroid autoimmune disorders / or thyroid cancer?
Do you avoid the use of beta blockers when treating hyperthyroidism in patients with well controlled asthma or COPD?
Does solid/trabecular type papillary thyroid carcinoma pathology confer a higher risk of recurrence and warrant radioactive iodine ablation therapy?
How do you determine when to treat versus monitor subclinical thyroid disease early in pregnancy in patients with a negative TPOAb?
What is the role of metformin in treating Hashimoto's disease?
